These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 27808571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CTLA-4 and CD86 genetic variants and haplotypes in patients with rheumatoid arthritis in southeastern China.
    Liu CP, Jiang JA, Wang T, Liu XM, Gao L, Zhu RR, Shen Y, Wu M, Xu T, Zhang XG.
    Genet Mol Res; 2013 Apr 25; 12(2):1373-82. PubMed ID: 23661460
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD28, CTLA-4 and CCL5 gene polymorphisms in patients with rheumatoid arthritis.
    Luterek-Puszyńska K, Malinowski D, Paradowska-Gorycka A, Safranow K, Pawlik A.
    Clin Rheumatol; 2017 May 25; 36(5):1129-1135. PubMed ID: 27988812
    [Abstract] [Full Text] [Related]

  • 7. Protein tyrosine phosphatase non-receptor type 22 (PTPN22) +1858 C>T gene polymorphism in Egyptian cases with rheumatoid arthritis.
    Salama A, Elshazli R, Elsaid A, Settin A.
    Cell Immunol; 2014 Jul 25; 290(1):62-5. PubMed ID: 24880676
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population.
    Hussein YM, El-Shal AS, Rezk NA, Abdel Galil SM, Alzahrani SS.
    Cytokine; 2013 Mar 25; 61(3):849-55. PubMed ID: 23394902
    [Abstract] [Full Text] [Related]

  • 11. sE-Selectin expression and A561C polymorphism in relation to rheumatoid arthritis clinical activity.
    Navarro-Hernández RE, Oregón-Romero E, Rangel-Villalobos H, Vázquez-Del Mercado M, Ruiz-Quezada SL, Maldonado-González M, Torres-Vitela R, Muñoz-Valle JF.
    J Rheumatol; 2006 Oct 25; 33(10):1968-72. PubMed ID: 17014013
    [Abstract] [Full Text] [Related]

  • 12. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R, Erken E, Dinkci S.
    Cell Biochem Biophys; 2013 Mar 25; 65(2):181-6. PubMed ID: 22923220
    [Abstract] [Full Text] [Related]

  • 13. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W, Kasitanon N, Wongthanee A, Kuwata S, Takeuchi F.
    Int J Rheum Dis; 2021 Nov 25; 24(11):1378-1385. PubMed ID: 34533895
    [Abstract] [Full Text] [Related]

  • 14. Decoding the genetic influence of CT60 non-coding polymorphism in CTLA-4 gene and sCTLA-4 biomarker with rheumatoid arthritis in the Indian population.
    Shamala V, Asha Devi S.
    Mol Biol Rep; 2024 Sep 28; 51(1):1023. PubMed ID: 39340674
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cytotoxic T-lymphocyte antigen-4-CT60 polymorphism in rheumatoid arthritis.
    Orozco G, Torres B, Núñez-Roldán A, González-Escribano MF, Martín J.
    Tissue Antigens; 2004 Dec 28; 64(6):667-70. PubMed ID: 15546339
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.